Literature DB >> 17427007

[Genetic immunization: new ways for protective and therapeutic vaccines against allergic diseases].

Sandra Scheiblhofer1, Richard Weiss, Josef Thalhamer.   

Abstract

Gene vaccines have proven to be a powerful tool to induce anti-allergic immune responses. Their underlying functional principle is based on the recruitment of allergen-specific Th1 cells and the establishment of a Th1 cytokine milieu, which protects against the development of a Th2-biased response and balances an already ongoing Th2-type response. Genetic immunization also offers novel approaches to the major problems associated with protein immunization, such as crosslinking of preexisting IgE on mast cells/basophils or induction of de novo synthesis of IgE by the protein immunization itself. In addition to the description of the principles of gene vaccination, this review gives a short overview of recently developed anti-allergic gene vaccines with an optimized efficacy and safety profile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17427007     DOI: 10.1007/s10354-007-0392-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  42 in total

1.  Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11.

Authors:  Ho Jen Peng; Song Nan Su; Zo Nan Chang; Pei Ling Chao; Shu Wen Kuo; Lai Chen Tsai
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

2.  Expression and immunogenicity of the major house dust mite allergen Der p 1 following DNA immunization.

Authors:  Claudia Betina Wolfowicz; TaoQi HuangFu; Kaw Yan Chua
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

3.  Inhibition of specific IgE response in vivo by allergen-gene transfer.

Authors:  C H Hsu; K Y Chua; M H Tao; S K Huang; K H Hsieh
Journal:  Int Immunol       Date:  1996-09       Impact factor: 4.823

Review 4.  The germless theory of allergic disease: revisiting the hygiene hypothesis.

Authors:  M Wills-Karp; J Santeliz; C L Karp
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

5.  Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.

Authors:  W W Leitner; H Ying; D A Driver; T W Dubensky; N P Restifo
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

6.  Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization.

Authors:  C H Hsu; K Y Chua; M H Tao; Y L Lai; H D Wu; S K Huang; K H Hsieh
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

7.  Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization.

Authors:  A Hartl; J Kiesslich; R Weiss; A Bernhaupt; S Mostböck; S Scheiblhofer; H Flöckner; M Sippl; C Ebner; F Ferreira; J Thalhamer
Journal:  Int Arch Allergy Immunol       Date:  1999-09       Impact factor: 2.749

8.  TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

Authors:  Shawn Babiuk; Neeloffer Mookherjee; Reno Pontarollo; Phillip Griebel; Sylvia van Drunen Littel-van den Hurk; Rolf Hecker; Lorne Babiuk
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

9.  Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling.

Authors:  Elizabeth R Jarman; Jonathan R Lamb
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.